Phio Pharmaceuticals Corp. · NASDAQ:PHIO
Orca Capital AG reported a 6.50% stake in Phio Pharmaceuticals Corp. (Schedule 13G/A)
Event Nov 20, 2025 · Filed Nov 24, 2025
Orca Capital AG reported a 6.50% stake in Phio Pharmaceuticals Corp., 700,421 shares, as a passive investor on Nov 20, 2025. Filed Nov 24, 2025 (Schedule 13G/A).
- Stake
- 6.50%
- Shares
- 700,421
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Orca Capital AG | 6.50% | 700,421 |
Source
Related
- Phio Pharmaceuticals Corp.
- Orca Capital AG
- Phio Pharmaceuticals Corp. shareholders
- Schedule 13G/A · Orca Capital AG · Dec 11, 2025
- Schedule 13G/A · Orca Capital AG · Nov 12, 2025
- Schedule 13G/A · Orca Capital AG · Nov 6, 2025
- Schedule 13G/A · Orca Capital AG · Aug 7, 2025
- Schedule 13G · Orca Capital AG · Jan 23, 2025
- Form 4 · Plott Ronald Todd · Sep 30, 2026
- Form 4 · Bitterman Robert J · Sep 29, 2026
- Form 4 · Plott Ronald Todd · Sep 29, 2026
- Form 4 · Carson Lisa Cabott · Sep 29, 2026
- Form 4 · Bradford Patricia A · Sep 25, 2026